Detalles de la búsqueda
1.
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
J Biol Chem;
293(12): 4334-4349, 2018 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29414775
2.
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy.
ACS Med Chem Lett;
12(3): 494-501, 2021 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33738077
3.
Conformational-Analysis-Guided Discovery of 2,3-Disubstituted Pyridine IDO1 Inhibitors.
ACS Med Chem Lett;
12(7): 1143-1150, 2021 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34267885
4.
Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1.
Mol Cancer;
9: 209, 2010 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20687910
5.
Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model.
Mol Cancer Ther;
8(2): 315-23, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19208826
6.
Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFßR1 Inhibitor as an Immuno-oncology Agent.
ACS Med Chem Lett;
11(2): 172-178, 2020 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071685
7.
Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
Cancer Res;
67(4): 1520-6, 2007 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17308090
8.
2-Methoxyestradiol modulates beta-catenin in prostate cancer cells: a possible mediator of 2-methoxyestradiol-induced inhibition of cell growth.
Int J Cancer;
122(3): 567-71, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17935127
9.
Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.
Cancer Lett;
254(1): 63-70, 2007 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-17383817
10.
Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.
Sci Rep;
7(1): 1220, 2017 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28450698
11.
Epidermal growth factor receptor: is a novel therapeutic target for pancreatic cancer?
Front Biosci;
10: 1763-7, 2005 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15769665
12.
Influence of the organophosphorus insecticide phosphamidon on lentic water.
J Environ Biol;
25(3): 359-63, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15847349
13.
2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis.
Mol Cancer Ther;
9(3): 523-34, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20197389
14.
Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2.
Cancer Res;
68(12): 4580-7, 2008 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18559502
15.
CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.
Cancer Res;
68(18): 7606-12, 2008 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18794149
16.
Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1.
Mol Carcinog;
45(11): 871-80, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16847823
17.
Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways.
Biochemistry;
45(11): 3703-13, 2006 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-16533053
18.
Molecular basis of protective effect by crocetin on survival and liver tissue damage following hemorrhagic shock.
Mol Cell Biochem;
278(1-2): 139-46, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16180099
Resultados
1 -
18
de 18
1
Próxima >
>>